Search
for
Sort by
Research 931–960 of 1000+
- Comparison of metformin and N-acetylcysteine on metabolic parameters in women with polycystic ovarian syndrome
- Cardiometabolic and neuroimaging correlates of cognitive function in polycystic ovary syndrome
- A computationally inferred regulatory heart aging model including post-transcriptional regulations
- Peri-operative Antithrombotic Therapy in Hair Transplantation
- Caring for women with polycystic ovary syndrome
- New-onset systemic lupus erythematosus during pregnancy: A challenge in diagnosis
- Plaque psoriasis
- Compounding as a Current Therapeutic Option in Dermatology
- Androgenisierung
- Cicatricial Alopecias
- Acupuncture in Polycystic Ovary Syndrome: Potential and Challenge
- Scarring Alopecia
- "Grievances at the treatment she received": Harriet E. Wilson's Spiritualist Career in Boston, 1868-1900
- Structure and Function of the Skin
- Isotretinoin
- Treatment guidelines in adult women
- Primary cicatricial alopecias
- Treatment of acne vulgaris: a literature review / Lečenje običnih akni (acne vulgaris) – pregled literature
- Comparative Study Between 2% Minoxidil Topical Spray vs. Intradermal Injection (Mesotherapy) for Treatment of Androgenetic Alopecia in Female Patients: A Controlled, 4-month Randomized Trial
- Biotransformation of Finasteride (MK-0906) by Selenastrum capricornutum (Green Algae)
- Haut und Haar
- Trelles-Jaeger Lid Plate
- Alopecia in three women of southeast asian descent with chronic renal failure: Possible association with erythropoietin use
- Gene Therapy: Recent Advances and Applications in Dermatology
- Investigating drug induced alopecia
- STEROID HORMONES IN GERIATRICS
- Scalpel, Toxin, and Performance Pressure: Metabolic, Psychiatric, and Psychosocial Aspects of Aesthetic Medicine in Competitive and Physique Athletes
- Fractional microneedle radiofrequency for photoaging and atrophic acne scar: a split-face clinical observation of two devices
- Molecular Mechanisms and Therapeutic Advances in Androgenetic Alopecia
- Pediatric Endocrine-Disrupting Chemical Exposure Produces Irreversible Organizational Injury: Biomarker Evidence Necessitating a Precautionary Public Health Framework